Antiretroviral Therapy 2016-2017: The Continuing Need for Individualized Therapy to Optimize Outcomes Among Diverse HIV Patients
Source: Antiretroviral Therapy 2016-2017: The Continuing Need for Individualized Therapy to Optimize Outcomes Among Diverse HIV Patients

Slideset

Antiretroviral Therapy 2016-2017: The Continuing Need for Individualized Therapy to Optimize Outcomes Among Diverse HIV Patients

In this downloadable slideset, Danielle Ciuffetelli, PharmD, and Elly Fatehi, PharmD, BCPS, review important considerations when selecting initial ART and explore how formularies can be better managed to ensure delivery of optimal care for diverse populations of HIV-infected patients. Illustrative cases provide useful examples of key factors involved in treatment selection, including comorbidities, patient preferences and disposition, concomitant medications, and childbearing potential.
Format: Microsoft PowerPoint (.ppt)
File size: 2.46 MB
Date posted: 1/10/2017
  • How New Data From CROI 2017 May Renew Interest in NNRTIs

    Charles B. Hicks MD - 4/21/2017    
    How do phase III data on doravirine affect the potential for future therapy with NNRTIs?
  • The Promise of Long-Acting Injectable Antiretroviral Therapies

    Paul E. Sax MD - 4/12/2017    
    Will long-acting cabotegravir plus rilpivirine injections satisfy patient desire for less frequent dosing? Here is my take.
  • An Aging Woman With Renal Disease and BMD Concerns: Is Dual Therapy an Option?

    Paul E. Sax MD - 4/11/2017    1 comment / Last Comment: 4/22/2017
    Here is my take on current data with dual-therapy regimens and when they might be considered.
  • Avoiding Drug Interactions Among Hormonal Oral Contraceptives and ARVs

    Kathleen E. Squires MD - 4/10/2017    
    Which ARV classes best avoid DDIs with hormonal contraception?
  • Optimal ART During Late Pregnancy After a Break in Therapy

    Kathleen E. Squires MD - 4/20/2017    
    Which regimen may work best during the third trimester?